Table 4.
Pharmacokinetic parameters after intravenous administration of APT-IE and APT-SL to rats (n = 6).
| Parameter | APT-IE | APT-SL |
|---|---|---|
| Cmax (μg·mL−1) | 32.95 ± 5.09* | 14.2 ± 4.12 |
| AUC(0–∞) (h·μg·mL−1) | 39.72 ± 3.17* | 12.72 ± 2.42 |
| MRT(0–t) (h) | 2.72 ± 0.09* | 2.05 ± 0.22 |
| T1/2 (h) | 4.14 ± 1.08 | 4.88 ± 1.87 |
| Vd (L·kg−1) | 1.76 ± 0.42* | 6.49 ± 2.48 |
| CL (L·h·kg−1) | 0.30 ± 0.02* | 0.94 ± 0.14 |
Compared APT-SL, P < 0.05, significant.